TotalMarketCap

YD Bio

YDESNasdaq United StatesHealth CareMedical Specialities

Market cap

$511.402 M

$7.22 +3.88%

Close of 6 Nov 2026

As of 6 Nov 2026, YD Bio (YDES) has a market capitalization of $511.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$596.8K

#3499 by revenue

Earnings

-$8.31M

Loss-making

Shares outstanding

70,789,261

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

YD Bio lists more than one class of stock. Company figures above cover all classes combined.

YDESW

Medical Specialities, ranked by market cap

All 44 →
  1. #29FreenomeFRNM$1.12B
  2. #30Castle BiosciencesCSTL$1.05B
  3. #31YD BioYDES$511.4M
  4. #32Fulgent GeneticsFLGT$511.0M
  5. #33TriSalus Life SciencesTLSI$217.4M

What if YD Bio were worth as much as…

Open the what-if tool →

Gold $28.2T

$398,649.40

Per share 55,215× higher

Bitcoin $1.53T

$21,570.23

Per share 2,988× higher

Apple $5.02T

$70,813.04

Per share 9,808× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for YD Bio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.